Report Detail
Global Cancer Treatment Drugs Market Growth 2019-2024
- RnM2996585 |
- 21 February, 2019 |
- Global |
- 175 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
According to this study, over the next five years the Cancer Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Treatment Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Cancer Treatment Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cancer Treatment Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cancer Treatment Drugs Consumption 2014-2024
- 2.1.2 Cancer Treatment Drugs Consumption CAGR by Region
- 2.2 Cancer Treatment Drugs Segment by Type
- 2.2.1 Chemotherapy
- 2.2.2 Targeted Therapy
- 2.2.3 Immunotherapy
- 2.2.4 Hormonal Therapy (Biologic Therapy)
- 2.2.5 Others
- 2.3 Cancer Treatment Drugs Consumption by Type
- 2.3.1 Global Cancer Treatment Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Cancer Treatment Drugs Sale Price by Type (2014-2019)
- 2.4 Cancer Treatment Drugs Segment by Application
- 2.4.1 Blood Cancer
- 2.4.2 Breast Cancer
- 2.4.3 Gastrointestinal Cancer
- 2.4.4 Prostate Cancer
- 2.4.5 Respiratory/Lung Cancer
- 2.4.6 Other Cancers
- 2.5 Cancer Treatment Drugs Consumption by Application
- 2.5.1 Global Cancer Treatment Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Cancer Treatment Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Cancer Treatment Drugs Sale Price by Application (2014-2019)
3 Global Cancer Treatment Drugs by Players
- 3.1 Global Cancer Treatment Drugs Sales Market Share by Players
- 3.1.1 Global Cancer Treatment Drugs Sales by Players (2017-2019)
- 3.1.2 Global Cancer Treatment Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Cancer Treatment Drugs Revenue Market Share by Players
- 3.2.1 Global Cancer Treatment Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Cancer Treatment Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Cancer Treatment Drugs Sale Price by Players
- 3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Cancer Treatment Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Cancer Treatment Drugs by Regions
- 4.1 Cancer Treatment Drugs by Regions
- 4.1.1 Global Cancer Treatment Drugs Consumption by Regions
- 4.1.2 Global Cancer Treatment Drugs Value by Regions
- 4.2 Americas Cancer Treatment Drugs Consumption Growth
- 4.3 APAC Cancer Treatment Drugs Consumption Growth
- 4.4 Europe Cancer Treatment Drugs Consumption Growth
- 4.5 Middle East & Africa Cancer Treatment Drugs Consumption Growth
5 Americas
- 5.1 Americas Cancer Treatment Drugs Consumption by Countries
- 5.1.1 Americas Cancer Treatment Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Cancer Treatment Drugs Value by Countries (2014-2019)
- 5.2 Americas Cancer Treatment Drugs Consumption by Type
- 5.3 Americas Cancer Treatment Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cancer Treatment Drugs Consumption by Countries
- 6.1.1 APAC Cancer Treatment Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Cancer Treatment Drugs Value by Countries (2014-2019)
- 6.2 APAC Cancer Treatment Drugs Consumption by Type
- 6.3 APAC Cancer Treatment Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cancer Treatment Drugs by Countries
- 7.1.1 Europe Cancer Treatment Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Cancer Treatment Drugs Value by Countries (2014-2019)
- 7.2 Europe Cancer Treatment Drugs Consumption by Type
- 7.3 Europe Cancer Treatment Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cancer Treatment Drugs by Countries
- 8.1.1 Middle East & Africa Cancer Treatment Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Cancer Treatment Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Cancer Treatment Drugs Consumption by Type
- 8.3 Middle East & Africa Cancer Treatment Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Cancer Treatment Drugs Distributors
- 10.3 Cancer Treatment Drugs Customer
11 Global Cancer Treatment Drugs Market Forecast
- 11.1 Global Cancer Treatment Drugs Consumption Forecast (2019-2024)
- 11.2 Global Cancer Treatment Drugs Forecast by Regions
- 11.2.1 Global Cancer Treatment Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Cancer Treatment Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Cancer Treatment Drugs Forecast by Type
- 11.8 Global Cancer Treatment Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Roche
- 12.1.1 Company Details
- 12.1.2 Cancer Treatment Drugs Product Offered
- 12.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Roche News
- 12.2 Novartis
- 12.2.1 Company Details
- 12.2.2 Cancer Treatment Drugs Product Offered
- 12.2.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis News
- 12.3 Celgene
- 12.3.1 Company Details
- 12.3.2 Cancer Treatment Drugs Product Offered
- 12.3.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Celgene News
- 12.4 Bristol-Myers Squibb
- 12.4.1 Company Details
- 12.4.2 Cancer Treatment Drugs Product Offered
- 12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Bristol-Myers Squibb News
- 12.5 Amgen
- 12.5.1 Company Details
- 12.5.2 Cancer Treatment Drugs Product Offered
- 12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Amgen News
- 12.6 Johnson & Johnson
- 12.6.1 Company Details
- 12.6.2 Cancer Treatment Drugs Product Offered
- 12.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Johnson & Johnson News
- 12.7 Pfizer
- 12.7.1 Company Details
- 12.7.2 Cancer Treatment Drugs Product Offered
- 12.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer News
- 12.8 Takeda
- 12.8.1 Company Details
- 12.8.2 Cancer Treatment Drugs Product Offered
- 12.8.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Takeda News
- 12.9 Eli Lilly
- 12.9.1 Company Details
- 12.9.2 Cancer Treatment Drugs Product Offered
- 12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Eli Lilly News
- 12.10 AstraZeneca
- 12.10.1 Company Details
- 12.10.2 Cancer Treatment Drugs Product Offered
- 12.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 AstraZeneca News
- 12.11 Astellas
- 12.12 Merck & Co.
- 12.13 Sanofi
- 12.14 Bayer
- 12.15 Biogen Idec
- 12.16 Eisai
- 12.17 Teva
- 12.18 Otsuka
- 12.19 Merck KGaA
- 12.20 Ipsen
- 12.21 AbbVie
- 12.22 Gilead Sciences
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cancer Treatment Drugs . Industry analysis & Market Report on Cancer Treatment Drugs is a syndicated market report, published as Global Cancer Treatment Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Cancer Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
